Mina Chen

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Neuronal differentiation regulator CEND1 coordinately suppresses tumor growth and energetics via AMPK signaling in brain glioma.

Neuronal differentiation regulator CEND1 coordinately suppresses tumor growth and energetics via AMPK signaling in brain glioma.

Journal: Cell & bioscience

Published: June 17, 2025

Chemotherapy induces multiple sclerosis-like neuropathologies that can be rescued by clobetasol.

Chemotherapy induces multiple sclerosis-like neuropathologies that can be rescued by clobetasol.

Journal: Cell death and differentiation

Published: May 29, 2025

Redox regulator LanCL1 suppresses glioma progression by coordinately inhibiting cell growth and regulating mitochondrial metabolism.

Redox regulator LanCL1 suppresses glioma progression by coordinately inhibiting cell growth and regulating mitochondrial metabolism.

Journal: Free radical biology & medicine

Published: April 08, 2025

Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1/2 signaling.

Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1/2 signaling.

Journal: Oncogene

Published: March 17, 2025

Integrative Analysis Identifies NSUN2 as an Essential Coordinator for Glioma Malignancy and Glucose Metabolism.

Integrative Analysis Identifies NSUN2 as an Essential Coordinator for Glioma Malignancy and Glucose Metabolism.

Journal: The journal of gene medicine

Published: June 05, 2024

Repeated ablations of mature Tmem10+ oligodendrocytes recapitulates key pathological features of multiple sclerosis with prolonged demyelination.

Repeated ablations of mature Tmem10+ oligodendrocytes recapitulates key pathological features of multiple sclerosis with prolonged demyelination.

Journal: Cell death & disease

Published: January 18, 2024

Integrative analysis defines DDIT3 amplification as a correlative and essential factor for glioma malignancy.

Integrative analysis defines DDIT3 amplification as a correlative and essential factor for glioma malignancy.

Journal: American journal of cancer research

Published: August 24, 2023

MEOX2 promotes glioma growth and temozolomide chemoresistance.

MEOX2 promotes glioma growth and temozolomide chemoresistance.

Journal: Journal of pharmaceutical analysis

Published: August 22, 2023

Impact of redox-related genes on tumor microenvironment immune characteristics and prognosis of high-grade gliomas.

Impact of redox-related genes on tumor microenvironment immune characteristics and prognosis of high-grade gliomas.

Journal: Frontiers in cellular neuroscience

Published: February 01, 2023

Disruption of neuronal RHEB signaling impairs oligodendrocyte differentiation and myelination through mTORC1-DLK1 axis.

Disruption of neuronal RHEB signaling impairs oligodendrocyte differentiation and myelination through mTORC1-DLK1 axis.

Journal: Cell reports

Published: January 06, 2023

Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma.

Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma.

Journal: Frontiers in pharmacology

Published: October 04, 2022

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas.

Journal: Frontiers in pharmacology

Published: September 06, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026